THE BEST SIDE OF ABBV-744 CLINICAL TRIAL PHASE 2 DATA

In Segment A, contributors will get distinct doses and schedules of oral ABBV-744 tablet to detect Harmless dosing routine. Further participants are going to be enrolled with the identified monotherapy dosign program. In Segment B, contributors will get oral ruxolitinib and ABBV-744 might be presented as "include-on" therapy. In Phase C, members wi